Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates


  • 18 Accesses

  • 2 Citations

This is a preview of subscription content, log in to check access.


  1. 1.

    Bornstein MB, Miller AI, Teitelbaum D, et al (1982) Multiple sclerosis: trial of a synthetic polypeptide. Ann Neurol 11: 317–319

  2. 2.

    Bornstein MB, Miller A, Slagle S, et al (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis. N Engl J Med 317:408–414

  3. 3.

    Bornstein MB, Miller A, Slagle S, et al (1991) A placebo-controlled, doubleblind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41:533–539

  4. 4.

    Johnson KP, Brooks BR, Cohen JA, et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268–1276

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Johnson, K.P. Introduction. J Neurol 243, S1–S2 (1996). https://doi.org/10.1007/BF00873694

Download citation